Vortrag
First Clinical Results Following Implantation of the EVO Viva EDoF-ICL
In his presentation at the 43rd ESCRS Congress in Copenhagen, Dr. Detlev R.H. Breyer discusses the initial results achieved by his patients following implantation of the EVO Viva EDoF-ICL (Staar Surgical).
Initial Clinical Results Following Implantation of the First EVO Viva EDoF-ICL
EVO Viva: the EDoF ICL for correcting presbyopia
The implantable contact lens is placed in the posterior chamber of the eye, which is located between the iris and the eye’s natural lens. The EVO Viva ICL is designed to provide an extended depth of field, enabling clear vision from near to far; reading glasses are needed only for small print.
This model is suitable for presbyopic patients between the ages of 40 and 60 with myopia ranging from -5 to -20 dpt who wish to be free from glasses. Two options are available:
As a phakic lens—that is, in addition to the eye’s natural lens—for people who are nearsighted and have presbyopia but still have a clear natural lens and therefore do not wish to undergo refractive lens exchange. – This lens is also a good choice for those with thinner corneas.
As an alternative to an add-on IOL for people who already have a monofocal intraocular lens (IOL) in their eye.
Our satisfied patients were able to read on their cell phones or in books and work on their computers without reading glasses. They needed glasses for small print.
Dr. Detlev R.H. Breyer
High Patient Satisfaction
Our patients received an EVO Viva ICL with a target refraction of -1.5 D. Preoperative and postoperative examinations included refraction, uncorrected and best-corrected distance and near visual acuity, subjective patient satisfaction, and the defocus curve.